Cullinan Therapeutics (CGEM) Earnings Date & Reports

Cullinan Therapeutics Inc is a biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CGEM is expected to report earnings to rise 11.74% to -81 cents per share on May 20

Cullinan Therapeutics CGEM Stock Earnings Reports

Q1'25

Est.

$-0.82

Q4'24

Beat

by $0.06

Q3'24

Beat

by $0.10

Q2'24

Missed

by $0.02

Q1'24

Beat

by $0.13

The last earnings report on March 03 showed earnings per share of -73 cents, beating the estimate of -79 cents. With 250.65K shares outstanding, the current market capitalization sits at 476.29M.

View a ticker or compare two or three

Compare

CGEM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CGEM
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CGEM (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Main Street

Phone

+1 617 410-4650

Employees

Web

https://www.cullinanoncology.com